Business Context and Reporting Period
PROCEPT BioRobotics Corporation (PRCT) filed a Form 8-K on October 29, 2024, reporting the closing of a public offering of common stock. The offering closed on October 31, 2024.
Key Financial Metrics
- Shares Issued: 1,923,076 shares of common stock.
- Offering Price: $91.00 per share.
- Over-Allotment Option: Underwriters exercised their option in full to purchase an additional 288,461 shares on October 30, 2024.
- Net Proceeds: Approximately $163.8 million received by the Company after deducting underwriting discounts, commissions, and estimated offering expenses.
- Selling Stockholder Proceeds: The Company received no proceeds from the sale of shares by the Selling Stockholder.
Material Changes
This filing represents a significant capital raise event. The Company's cash position increased by approximately $163.8 million upon the closing of the transaction. The filing does not provide comparative financial data for prior periods as it is a current report regarding a specific transaction rather than a periodic financial statement.
Guidance, Outlook, and Risks
- Lock-Up Agreement: The Company, its directors, and executive officers agreed to a 60-day lock-up period from the date of the prospectus supplement, prohibiting the sale or transfer of common stock without the written consent of the underwriters, subject to certain exceptions.
- Underwriters: BofA Securities, Inc., Piper Sandler & Co., and Morgan Stanley & Co., LLC served as representatives.
- Legal Opinions: The validity of the securities was confirmed by Latham & Watkins LLP.
Investor Verification Checklist
- Verify the final total share count issued including the full exercise of the over-allotment option.
- Confirm the exact amount of net proceeds after all final offering expenses are settled.
- Review the specific exceptions to the 60-day lock-up agreement for directors and officers.
- Check subsequent filings for the intended use of the $163.8 million in proceeds.